Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Crit Care Med. 2018 May;46(5):713–719. doi: 10.1097/CCM.0000000000002988

Table 2.

Prevalence of PTSD Diagnoses and Symptom Severity by Time Point

Assessment Time Points Meeting Clinical Significance N (%) Symptom Severity M (SD)
Baseline (N=99) 16 (16.2%) 28.52 (12.11)
3-Month Post-Hospitalization (N=79) 14 (17.7%) 30.41 (12.11)
6-Month Post-Hospitalization (N=79) 17 (21.5%) 30.03 (14.59)

Note. Clinical significance for PTSD as determined on the Post-Traumatic Checklist-Specific Stressor (PCL-S) by symptoms rated “moderately” or above for at least: one B cluster item (questions 1-5); three C cluster items (questions 6-12); and two D cluster items (questions 13-17).